EUCTR2015-001946-26-DK进行中（未招募）1 期
Amilorid treatment of nephrotic edema - AMITNED
Aarhus University Hospital0 个研究点目标入组 40 人开始时间: 2015年10月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- First episode of NS
- •- Age 1 to 15 yrs
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Relapse of NS or secondare NS
- •- Dehydration
- •- Treatment with prednisolon/diuretics 1 mth prior inclusion
- •- PLasma K above 5,5 mmol/l
- •- Decreased renal function
- •- Known allergy to amilorid
- •- Pregnancy
研究者
相似试验
进行中（未招募）
1 期
AMIND - AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with bipolar disorder treated with lithium: a randomized controlled trialCTIS2024-515018-42-00Assistance Publique Hopitaux De Paris148
终止
3 期
Amiloride in Nephrotic SyndromeEdemaSodium RetentionNephrotic SyndromeNCT05079789University Hospital Tuebingen20
已完成
不适用
Increased Activity of ENaC in Proteinuric Kidney Transplant RecipientsKidney Transplant ComplicationsNCT03036748University of Southern Denmark14
Unknown
不适用
Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney DiseaseDiabetic NephropathiesHypertensionNCT01918488University of Southern Denmark80
进行中（未招募）
不适用
Traitement de la nephropathie à cylindres myelomateux. MYRE - MYREMyélome multiple compliqué d'insuffisance rénale par néphropathie à cylindre myélomateux.MedDRA version: 8.1Level: PTClassification code 10029151Term: Traitement de la nephropathie à cylindres myelomateuxEUCTR2009-017926-38-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)